PARIS, June 15 (Reuters) - A deal between AstraZeneca
and France over potential COVID-19 vaccines foresees
doses being split between countries on a pro-rata basis based on
population, a source at the French President's office said on
Monday.
The British drugmaker signed a contract with European
governments at the weekend to supply the region with up to 400
million doses of its potential vaccine. The source at the French
president's office added that France hopes to strike similar
deals with other pharmaceuticals companies soon.
(Reporting by Michel Rose and Matthias Blamont
Editing by David Goodman)